This result is in agreement with what has already been described in previous studies in which the deregulation of PTEN expression, via binding sites for RNA-binding-protein and miRNA located in 3′UTR, was associated with aggressive phenotype and poor outcome for BC patients [16,17]. The gene discussed is PTEN; the disease is breast cancer.